# Insulet to invest $200M in Johor manufacturing facility

Insulet Corporation is investing about $200 million over five years to build a new manufacturing facility in Gelang Patah, Johor, Malaysia, to produce the Omnipod Insulin Management System. The facility is expected to be operational by mid-2024 and will create over 500 jobs.

- Type: New facility
- Announced: 2022-02-06
- Where: Gelang Patah, Johor, Malaysia
- Value: $200.0M
- Jobs: 500
- Starts operating: Q3 2024
- Status: under construction
- Capacity: approximately 400,000 square feet of manufacturing space
- Products: Omnipod Insulin Management System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Insulet Corp.](https://endata.com/companies/20641.md)

## Sources

- [bernama.com](https://www.bernama.com/en/news.php?id=2087381), 2022-02-06: "Insulet is investing about US$200 million over the next five years for its new manufacturing facility in Johor as part of the company’s strategy to further strengthen its global manufacturing capabilities."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.